SCHEMBL7098243

SCHEMBL7098243

Cc1cc(C2C(=O)NC(C)C2=O)c(Cl)cc1-c1ccccc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR2 Q92731 1/20 0.35
PDE3B Q13370 2/20 0.34
PDE3A Q14432 2/20 0.34
PDE4A P27815 1/20 0.34
PDE4B Q07343 1/20 0.34
PDE4C Q08493 1/20 0.34
PDE4D Q08499 1/20 0.34
TRPM2 O94759 2/20 0.33
MAOA P21397 1/20 0.33
MAOB P27338 1/20 0.33
KDM4E B2RXH2 3/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
ALDH1A1 P00352 3/20 0.32
HTT P42858 1/20 0.32
DHFR P00374 1/20 0.32
GAA P10253 1/20 0.32
HSD17B10 Q99714 2/20 0.31
CYP1A1 P04798 1/20 0.31
CYP1A2 P05177 1/20 0.31
MEN1 O00255 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL812401 0.80 PGR (0.40) ESR2SMN1; SMN2ALDH1A1HTTGAA
SCHEMBL8650400 0.72 GAA (0.54) KDM4ESMN1; SMN2ALDH1A1HTTGAA
SCHEMBL7098248 0.72 ELANE (0.36) KDM4ESMN1; SMN2ALDH1A1HSD17B10CYP1A2
SCHEMBL7098246 0.70 ALDH1A1 (0.38) ALDH1A1GAAMEN1LMNAKMT2A
SCHEMBL20779245 0.67 ESR2 (0.48) ESR2DHFRCYP1A2LMNAHPGD
SCHEMBL5771881 0.65 MAPT (0.33) KDM4EALDH1A1MEN1LMNAKMT2A
SCHEMBL812402 0.64 PGR (0.49) MAOBALDH1A1HPGD
SCHEMBL13176917 0.63 ESR2 (0.48) ESR2DHFRCYP1A1CYP1A2LMNA
SCHEMBL4830408 0.62 ESR2 (0.60) ESR2PDE3BPDE3APDE4APDE4B
SCHEMBL6207998 0.61 ALDH1A1 (0.49) KDM4ESMN1; SMN2ALDH1A1GAAHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030096806-A1 Arylphenyl-substituted cyclic ketoenols LIEB FOLKER (DE) 2003-05-22 US disclosed
US-6451843-B1 Arylphenyl-substituted cyclic keto enols BAYER AKTIENGESELLSCHAFT (DE) 2002-09-17 US disclosed
EP-1075465-A1 ARYLPHENYL-SUBSTITUTED CYCLIC KETO ENOLS BAYER AG (DE) 2001-02-14 EP disclosed
WO-1999055673-A1 ARYLPHENYL-SUBSTITUTED CYCLIC KETO ENOLS BAYER AKTIENGESELLSCHAFT (DE) 1999-11-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030096806-A1 Arylphenyl-substituted cyclic ketoenols KCNE1, KCNQ3, SULT1E1 ESR2 1499/4885PDE3B 2145/4885PDE3A 2103/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.